Combination of Tipifarnib and Sunitinib Overcomes Renal Cell Carcinoma Resistance to Tyrosine Kinase Inhibitors via Tumor-Derived Exosome and T Cell Modulation is a research paper published in Cancers (2022). On theSindex it has a DataRank of 0. It has been cited 34 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: U54 GM104940
National Institutes of Health
Grant: 3U54GM104940-07S3
Louisiana Clinical and Translational Science Center Supplement - COVID Sequence Surveillance Network
National Institutes of Health
Grant: 5P20CA233374-03
Understanding and Addressing Cancer Health Disparities in Louisiana
FWCI
3.95
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals